{"id":"https://openalex.org/W2000203156","doi":"https://doi.org/10.1358/mf.2007.29.3.1075351","title":"Antiaggressive effects of topiramate in agonistic encounters between male mice","display_name":"Antiaggressive effects of topiramate in agonistic encounters between male mice","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W2000203156","doi":"https://doi.org/10.1358/mf.2007.29.3.1075351","mag":"2000203156","pmid":"https://pubmed.ncbi.nlm.nih.gov/17520101"},"language":"en","primary_location":{"id":"doi:10.1358/mf.2007.29.3.1075351","doi":"https://doi.org/10.1358/mf.2007.29.3.1075351","is_oa":false,"landing_page_url":"https://doi.org/10.1358/mf.2007.29.3.1075351","pdf_url":null,"source":{"id":"https://openalex.org/S17778739","display_name":"Methods and Findings in Experimental and Clinical Pharmacology","issn_l":"0379-0355","issn":["0379-0355","2013-0155"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310313017","host_organization_name":"Thomson Reuters","host_organization_lineage":["https://openalex.org/P4310313017"],"host_organization_lineage_names":["Thomson Reuters"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods and Findings in Experimental and Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063573432","display_name":"Jos\u00e9 Francisco Navarro","orcid":"https://orcid.org/0000-0002-5104-8974","observed_orcids":["https://orcid.org/0000-0002-5104-8974"]},"institutions":[{"id":"https://openalex.org/I82767444","display_name":"Universidad de M\u00e1laga","ror":"https://ror.org/036b2ww28","country_code":"ES","type":"education","lineage":["https://openalex.org/I82767444"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Navarro, J.F.","raw_affiliation_strings":["Department of Psychobiology, Faculty of Psychology, University of Malaga, Spain. navahuma@uma.es"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychobiology, Faculty of Psychology, University of Malaga, Spain. navahuma@uma.es","institution_ids":["https://openalex.org/I82767444"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000209760","display_name":"Estrella Bur\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Buron, E.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048648461","display_name":"Mercedes Mart\u00edn\u2010L\u00f3pez","orcid":"https://orcid.org/0000-0002-6869-9669","observed_orcids":["https://orcid.org/0000-0002-6869-9669"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin-Lopez, M.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9101,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.65908483,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"29","issue":"3","first_page":"195","last_page":"195"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.48899999260902405,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.48899999260902405,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.46070000529289246,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":1.0},{"id":"https://openalex.org/keywords/antiaggressive-effects","display_name":"antiaggressive effects","score":0.847000002861023},{"id":"https://openalex.org/keywords/aggression","display_name":"aggression","score":0.8109999895095825},{"id":"https://openalex.org/keywords/agonistic-encounters","display_name":"agonistic encounters","score":0.8429999947547913},{"id":"https://openalex.org/keywords/male-mice","display_name":"male mice","score":0.9649999737739563},{"id":"https://openalex.org/keywords/offensive-behavior","display_name":"offensive behavior","score":0.6700000166893005},{"id":"https://openalex.org/keywords/burrowing-behavior","display_name":"burrowing behavior","score":0.9900000095367432},{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.7519999742507935},{"id":"https://openalex.org/keywords/ampa-receptors","display_name":"AMPA receptors","score":0.859000027179718},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.800000011920929},{"id":"https://openalex.org/keywords/ethnopharmacology","display_name":"ethnopharmacology","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.9204345941543579},{"id":"https://openalex.org/C187898756","wikidata":"https://www.wikidata.org/wiki/Q395324","display_name":"Agonistic behaviour","level":3,"score":0.8203616738319397},{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.5597328543663025},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.47725388407707214},{"id":"https://openalex.org/C2779448149","wikidata":"https://www.wikidata.org/wiki/Q191797","display_name":"Aggression","level":2,"score":0.46294036507606506},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.4491552710533142},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.368320494890213},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36803674697875977},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3538426160812378},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.353456974029541},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28525063395500183},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.16649454832077026},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.12951192259788513},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.07979691028594971}],"mesh":[{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000378","descriptor_name":"Agonistic Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1358/mf.2007.29.3.1075351","doi":"https://doi.org/10.1358/mf.2007.29.3.1075351","is_oa":false,"landing_page_url":"https://doi.org/10.1358/mf.2007.29.3.1075351","pdf_url":null,"source":{"id":"https://openalex.org/S17778739","display_name":"Methods and Findings in Experimental and Clinical Pharmacology","issn_l":"0379-0355","issn":["0379-0355","2013-0155"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310313017","host_organization_name":"Thomson Reuters","host_organization_lineage":["https://openalex.org/P4310313017"],"host_organization_lineage_names":["Thomson Reuters"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods and Findings in Experimental and Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:17520101","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17520101","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods and findings in experimental and clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3093964350","https://openalex.org/W3028577174","https://openalex.org/W4413016486","https://openalex.org/W3049502809","https://openalex.org/W2024461573","https://openalex.org/W4377564713","https://openalex.org/W2350357944","https://openalex.org/W2083426177","https://openalex.org/W2046015673","https://openalex.org/W2005089197"],"abstract_inverted_index":{"Topiramate,":[0],"an":[1,55,84,110],"antiepileptic":[2],"drug,":[3],"has":[4],"been":[5],"found":[6],"to":[7,63,102,149],"be":[8,147],"useful":[9],"for":[10,152],"the":[11,23,37,96],"treatment":[12],"of":[13,25,39,74,124,144,161],"aggression":[14],"in":[15,31,87],"clinical":[16],"populations.":[17],"However,":[18],"no":[19],"studies":[20],"have":[21],"explored":[22],"action":[24],"this":[26],"compound":[27],"on":[28,48],"aggressive":[29],"behavior":[30,134],"laboratory":[32],"animals.":[33],"This":[34],"work":[35],"examined":[36],"effects":[38,143],"topiramate":[40,117,145],"(10,":[41],"20,":[42],"40":[43],"and":[44,83,95,128],"80":[45],"mg/kg,":[46],"i.p.)":[47],"agonistic":[49],"interactions":[50,76],"between":[51,79],"male":[52],"mice,":[53],"using":[54,109],"ethopharmacological":[56],"approach.":[57],"Individually":[58],"housed":[59,82],"mice":[60],"were":[61,77,93],"exposed":[62],"anosmic":[64,85],"\"standard":[65],"opponents\"":[66],"30":[67],"min":[68],"after":[69],"drug":[70],"administration.":[71],"Ten":[72],"minutes":[73],"diadic":[75],"staged":[78],"a":[80,88,121],"singly":[81],"mouse":[86],"neutral":[89],"area.":[90],"The":[91,141],"encounters":[92],"videotaped":[94],"accumulated":[97],"time":[98],"allocated":[99],"by":[100],"subjects":[101],"10":[103],"broad":[104],"behavioral":[105],"categories":[106],"was":[107,137],"estimated":[108],"ethologically":[111],"based":[112],"analysis.":[113],"Results":[114],"showed":[115],"that":[116],"(20-80":[118],"mg/kg)":[119],"produced":[120],"significant":[122],"reduction":[123],"offensive":[125],"behaviors":[126],"(threat":[127],"attack),":[129],"without":[130],"affecting":[131],"immobility.":[132],"Digging":[133],"(all":[135],"doses)":[136],"also":[138],"significantly":[139],"decreased.":[140],"antiaggressive":[142],"could":[146],"related":[148],"its":[150],"ability":[151],"modulating":[153],"positively":[154],"GABA-A":[155],"receptors":[156],"and/or":[157],"blocking":[158],"AMPA":[159],"subtype":[160],"glutamate":[162],"receptors.":[163]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}